Protein S Antigen, Free
Protein S is a nonenzymatic cofactor that functions to inhibit coagulation by accelerating activated protein C proteolysis of clotting factors Va and VIIIa. Protein S is synthesized in the liver, and is dependent upon vitamin K to become fully functional. Approximately 40% of the total protein S antigen is unbound, while the other 60% is found in the inactive form, which is noncovalently bound to the beta chain of the complement regulatory C4b binding protein (C4bBP). Only the free, or unbound, protein S is able to react with activated protein C.
Free protein S antigen assays make use of monoclonal antibodies with specificity for free protein S. Protein S deficiency can be either an inherited or acquired disorder. The acquired form is more common. Each deficiency can be further subclassified depending on the levels of Protein S activity, free Protein S antigen and total Protein S antigen results. Inherited heterozygous deficiency can range from a mild to moderate risk for venous thromboembolism (VTE). Cases of homozygous deficiencies are rare and are associated with neonatal purpura fulminans which is often fatal. Acquired deficiencies are usually found secondary to other disease states.
- Diagnostic in evaluating patients for risk of thrombotic events
- Diagnosis of inherited protein S deficiency
- As an aid in evaluation of Hypercoagulable states or Thrombophilia
- As an aid in diagnosis of deep vein thrombosis (DVT)
- Evaluating patients with recurrent spontaneous abortion
Increased in:
- Postmenopausal women
- There is no clinical significance for an elevated Protein S level
Decreased in:
- Inherited heterozygous or homozygous deficiency
- Vitamin K deficiency
- Anticoagulant therapy
- Acute thrombosis of any type
- Liver disease
- Trauma
- Oral contraceptive use
- Pregnancy or estrogen therapy
- Nephrotic syndrome
- Sickle cell anemia
- Disseminated intravascular coagulation
- Thrombotic thrombocytopenic purpura
- Acute illness with resulting increase of the acute phase reactant C4bBP
Notes: Total Protein S antigen assay can be affected by Heparin > 4 U/ml, Hemoglobin > 200 mg/dL, Bilirubin > 25 mg/dL, Triglycerides > 1500 mg/dL, Platelets > 10(10)/L, Rheumatoid factor > 900 IU/mL, Factor V Leiden mutation.
1-89 days: 15-55%
90-179 days: 35-92%
180-364 days: 45-115%
1-5 years: 62-120%
6-9 years: 62-130%
10-17 years: 60-140%
18 years and older Male: 60-160%
18 years and older Female: 70-160%
Plasma Citrate (Light Blue)
Freeze immediately and maintain frozen until tested.
Stability
- Ambient: Unacceptable
- Refrigerated: Unacceptable
- Frozen: 14 days
- Harmening, Denise M. (1997). Clinical Hematology and Fundamentals of Hemostasis. 3rd edition. Philadelphia: F.A. Davis Company.
- Kottke-Merchant, Kandice. (2008). An Algorithmic Approach to Hemostasis Testing. Northfield: College of American Pathologists (CAP) Press.
- Zimmerman, A. Andrew, R. Scott Watson, and Joseph K. Williams. Protein S Deficiency Presenting as an Acute Postoperative Arterial Thrombosis in a 4-Year-Old Child. Anesth Analg.1999;88:535-537.